Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases

被引:1
|
作者
Nie, Shanshan [1 ]
Zhang, Shan [2 ]
Wu, Ruipeng [1 ]
Zhao, Yuhang [3 ]
Wang, Yongxia [1 ]
Wang, Xinlu [1 ]
Zhu, Mingjun [1 ]
Huang, Peng [4 ]
机构
[1] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Cardiovasc Dis, Zhengzhou, Henan, Peoples R China
[2] Henan Univ Chinese Med, Affiliated Hosp 1, Dept Digest Dis, Zhengzhou, Peoples R China
[3] Fudan Univ, Huashan Hosp, Dept Integrat Med, Shanghai, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 7, Dept Tradit Chinese Med, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
Scutellarin; pharmacological effects; therapeutic potential; chronic diseases; mechanisms; INDUCED ACUTE CARDIOTOXICITY; ISCHEMIA-REPERFUSION INJURY; HUMAN-NEUTROPHIL-ELASTASE; COLORECTAL-CANCER CELLS; FATTY LIVER-DISEASE; ACUTE LUNG INJURY; OXIDATIVE STRESS; IN-VITRO; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION;
D O I
10.3389/fphar.2024.1470879
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Scutellarin (SCU), a flavonoid glucuronide derived from Scutellaria barbata and Erigeron breviscapus, exhibits broad pharmacological effects with promising therapeutic potential in treating various chronic diseases. It has demonstrated efficacy in modulating multiple biological pathways, including antioxidant, anti-inflammatory, anti-apoptotic, and vasodilatory mechanisms. These protective roles make SCU a valuable compound in treating chronic diseases such as cerebrovascular diseases, cardiovascular diseases, neurodegenerative disorders, and metabolic diseases. Despite its multi-targeted effects, SCU faces challenges such as low bioavailability and limited clinical data, which hinder its widespread therapeutic application. Current research supports its potential to prevent oxidative stress, reduce inflammatory responses, and enhance cell survival in cells and rats. However, more comprehensive studies are required to clarify its molecular mechanisms and to develop strategies that enhance its bioavailability for clinical use. SCU could emerge as a potent therapeutic agent for the treatment of chronic diseases with complex pathophysiological mechanisms. This review examines the current literature on Scutellarin to provide a comprehensive understanding of its pharmacological activity, mechanisms of action, and therapeutic potential in treating chronic diseases.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Pharmacological effects and the related mechanism of scutellarin on inflammation-related diseases: a review
    Zhou, Yang
    Gu, Chenlin
    Zhu, Yan
    Zhu, Yuting
    Chen, Yutong
    Shi, Li
    Yang, Yang
    Lu, Xin
    Pang, Hanqing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [2] The Therapeutic Effects and Mechanisms of Quercetin on Metabolic Diseases: Pharmacological Data and Clinical Evidence
    Yi, Huan
    Peng, Hengyang
    Wu, Xinyue
    Xu, Xinmei
    Kuang, Tingting
    Zhang, Jing
    Du, Leilei
    Fan, Gang
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [3] Exercise Rehabilitation and Chronic Respiratory Diseases: Effects, Mechanisms, and Therapeutic Benefits
    Xiong, Ting
    Bai, Xinyue
    Wei, Xingyi
    Wang, Lezheng
    Li, Fei
    Shi, Hui
    Shi, Yue
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 1251 - 1266
  • [4] Repurposing Dimethyl Fumarate for Cardiovascular Diseases: Pharmacological Effects, Molecular Mechanisms, and Therapeutic Promise
    Thomas, Shilu Deepa
    Jha, Niraj Kumar
    Sadek, Bassem
    Ojha, Shreesh
    PHARMACEUTICALS, 2022, 15 (05)
  • [5] The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases
    Hu, Changfeng
    Lu, Lu
    Wan, Jie-Ping
    Wen, Chengping
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (20) : 2241 - 2249
  • [6] Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical
    Wang, Xinyue
    Yang, Shengjie
    Li, Yujuan
    Jin, Xiao
    Lu, Jing
    Wu, Min
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [7] Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
    Lee, Han Ah
    Chang, Young
    Sung, Pil Soo
    Yoon, Eileen L.
    Lee, Hye Won
    Yoo, Jeong-Ju
    Lee, Young-Sun
    An, Jihyun
    Song, Do Seon
    Cho, Young Youn
    Kim, Seung Up
    Kim, Yoon Jun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2022, 28 (03) : 425 - 472
  • [8] Effects of scutellarin on the mechanism of cardiovascular diseases: a review
    Zhang, Xinyu
    Yin, Tong
    Wang, Yincang
    Du, Jiazhe
    Dou, Jinjin
    Zhang, Xiwu
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [9] Insights into the pharmacological and therapeutic effects of apigenin in liver injuries and diseases
    Bi, Chenchen
    Han, Wenwen
    Yu, Jingru
    Zhang, Huafang
    Xing, Guiying
    Liu, Zheng
    HELIYON, 2023, 9 (05)
  • [10] Properties and molecular mechanisms underlying geniposide-mediated therapeutic effects in chronic inflammatory diseases
    Deng Ran
    Wu Hong
    Wang Yan
    Wang Mengdie
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 273